Farallon Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Farallon Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-245,000	Closed	-$10.1M	–	109
2015 Q2	$10.1M	Buy	+245,000	New	+$8.78M	0.14%	66

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Farallon Capital Management's BRLI Position: Q3 2015 in Review

Farallon Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 245,000 shares — an estimated $10.1M sold.

Farallon Capital Management first reported a position in BRLI in Q2 2015 and held it in 1 quarter. The position peaked at $10.1M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Farallon Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Farallon Capital Management sold 245,000 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $10.1M.
Farallon Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2015 and held it in 1 quarter.
Farallon Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $10.1M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Farallon Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.